President Trump’s 2025 executive order “Protecting Children From Chemical And Surgical Mutilation” aims to limit youth access to gender affirming care. The order has caused confusion and disruption of services, sparking a legal challenge and opposition from multiple states. Major provisions include restricting federal research grant recipients from providing gender affirming care and reinterpreting nondiscrimination protections. Misinformation also widely exists in the order. Seventeen state attorneys have responded, with 15 opposing the order. Lawsuits filed by the ACLU, Lambda Legal and others are contesting the order, terming it unconstitutional.
CISA, FDA Release Warning on Contec CMS8000 Firm
The U.S. Cybersecurity and Infrastructure Security Agency (CISA) and the U.S. Food and Drug Administration (FDA) have warned about cybersecurity vulnerabilities in Contec’s CMS8000 patient
